×

Gilead CEO: M&A is top of mind for us this year

5:07 PM ET Tue, 10 Jan 2017

John Milligan, Gilead president and CEO, speaks to CNBC's Meg Tirrell about potential M&A, drug-pricing pressure under President-elect Donald Trump and the company's hepatitis C drugs.